SEC Form 4 · accession 0001493152-17-010416
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel O'Connor
Director
Period of report
Sep 7, 2017
Accepted (ET)
Sep 11, 2017 · 6:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.08 | Sep 7, 2017 | A | 100,000 | A | Sep 7, 2017 | Sep 7, 2027 | Common Stock | 100,000 | 100,000 | D |
Remarks
(1) The shares subject to the stock option vest in 12 equal monthly installments, with the first 1/12th of such shares vesting on the first monthly anniversary of the date of grant.